+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Gastrointestinal Stent Market Analysis by Product, by Material, by Application, End user and by Region - Global Forecast to 2029

  • PDF Icon

    Report

  • 146 Pages
  • August 2022
  • Region: Global
  • Quintana Research and Consulting
  • ID: 5651424
The gastrointestinal stent market size is estimated to be USD 635 million in 2021 and is expected to witness a CAGR of 7.65% during the forecast period 2022-2029. The increased prevalence of GI malignancies and other gastrointestinal diseases, and changing lifestyles, growing healthcare expenditure on gastrointestinal treatments, and an increasing demand for less invasive surgery are some of the key drivers for the market growth. Additionally, the rising funding from the government organizations pharmaceutical research is projected to drive the market growth in near future. However, issues related with GI stent implementation is expected to restrain the market growth.

By Product

Based on product, the market is segregated into duodenal stents, biliary stents, pancreatic stents, esophageal stents, and colonic stents. In 2021, the esophageal stents segment accounted for the highest revenue share owing to the rise in biliary disease prevalence, rising incidence of chronic liver disease and bile duct cancer, and increase in surgical operations used to address biliary disorders.

By Material

On the basis of material, the market is categorized into nitinol, self-expanding metal stents, stainless steel, plastic stents, and other metal. In 2021, the self-expanding metal stents segment accounted for the highest revenue share due to rising demand among patients for its benefits which include a reduced risk of dislodgment or migration, ease of insertion, and extended patency.

By Application

Based on application, the market is segregated into colorectal cancer, stomach cancer, pancreatic cancer, biliary diseases, irritable bowel syndrome, and gastrointestinal cancers. In 2021, the gastrointestinal cancers segment accounted for the highest revenue share owing to the surge in stomach cancer incidences and prevalence.

By End user

On the basis of end user, the market is bifurcated into ambulatory surgical centers and hospitals & clinics. In 2021, the hospitals & clinics segment accounted for the highest revenue share due to rising government efforts to offer gastrointestinal illnesses quality care, extensive use of percutaneous transhepatic cholangiography (PTC), and endoscopic retrograde cholangio-pancreatography (ERCP) in hospitals for a variety of illness causes, and favorable circumstances for reimbursement.

Regional Markets

In 2021, North America region accounted for the highest revenue in the gastrointestinal stent market and is expected to maintain its dominance during the forecast period. This is attributed to the growing acceptance, developed healthcare infrastructure in the U.S and Canada, presence of leading players in this region, and government funding. Asia Pacific market is projected to exhibit the fastest CAGR over the forecast period owing to developing healthcare infrastructure, growing disposable income, and rising healthcare awareness in this region.

Competitor Insights

Some of the key players operating in the gastrointestinal stent market are Boston Scientific Corporation (US), Cook Group (US), Medtronic plc. (Ireland), ELLA-CS, s.r.o. (Czech Republic), Becton, Dickinson and Company (US), Merit Medical Systems (US), CONMED Corporation (US), Cantel Medical (US), Olympus Corporation (Japan), Taewoong Medical (South Korea), Micro-Tech(Nanjing) Co., Ltd. (China), Endo-Flex GmbH (Germany), MI-Tech (South Korea), Hobbs Medical Inc. (US), QualiMed (Germany), UK Medical (UK), CITEC (China), Medorah Meditek Pvt. Ltd. (India), BCM Corporation (South Korea), and Leufen Medical GmbH (Germany).

This comprehensive research report focuses on the global and regional market size and forecasts of diverse segments including product, material, application, and end user from 2021 to 2029.

Segmentation: Gastrointestinal Stent Market Report 2021-2029

Product (Revenue, USD Million)

  • Duodenal stents
  • Biliary stents
  • Pancreatic stents
  • Oesophageal stents
  • Colonic stents

By Material (Revenue, USD Million)

  • Nitinol
  • Self-expanding metal stents
  • Stainless Steel
  • Plastic stents

By Application (Revenue, USD Million)

  • Colorectal Cancer
  • Stomach Cancer
  • Pancreatic Cancer
  • Biliary Diseases
  • Irritable bowel syndrome
  • Gastrointestinal Cancers

By End user (Revenue, USD Million)

  • Ambulatory Surgical Centres
  • Hospitals & Clinics

By Region (Revenue, USD Million)

North America

  • U.S
  • Canada

Europe

  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM

Middle East & Africa

  • South Africa
  • GCC
  • Rest of MEA

Table of Contents

1. Research Methodology
1.1.Study Objectives
1.2.Study Scope
1.3.Research Assumptions
1.4.Research Framework
1.4.1.Research Models
1.4.1.1.Bottom-up Approach
1.4.1.2.Top-down Approach
1.4.1.3.Data Triangulation
1.4.2.Data Procurement
1.4.2.1.Internal Database
1.4.2.2.Secondary Research
1.4.2.3.Purchased Database
1.4.2.4.Primary Research
1.4.3.Data Analysis
1.4.3.1.Data Validation
1.4.3.2.Market Size Estimation
1.4.3.3.Market Forecast Model
1.4.4.Quality Assessment
2. Introduction: Gastrointestinal Stent
3. Executive Summary
3.1.Global Market Scenario
3.2.Segment Market Scenario
3.3.Geographic Market Scenario
3.4.COVID-19 Impact
3.5.Competitive Landscape
4. Market Dynamics
4.1. Market Drivers
4.1.1.Driver 1
4.1.2.Driver 2
4.1.3.Driver 3
4.1.4.Driver 4
4.1.5.Driver 5
4.2.Market Restraint
4.2.1.Restraint 1
4.2.2.Restraint 2
4.2.3.Restraint 3
4.2.4.Restraint 4
4.3.Market Opportunities
4.3.1.Opportunity 1
4.3.2.Opportunity 2
4.3.3.Opportunity 3
4.3.4.Opportunity 4
4.4.Market Trends
4.4.1.Trend 1
4.4.2.Trend 2
4.4.3.Trend 3
4.4.4.Trend 4
4.5.Market Challenges
4.5.1.Challenge 1
4.5.2.Challenge 2
4.5.3.Challenge 3
4.5.4.Challenge 4
5. Market Environment Analysis
5.1.Porter’s 5 Forces Analysis
5.2.PESTEL Analysis
5.3.Value Chain Analysis
5.4.SWOT Analysis
5.5.Benchmark
6. COVID-19 Impact Analysis: Gastrointestinal Stent Market
6.1.COVID-19: Overview
6.2.COVID-19 Impact on the Global Market
6.3.COVID-19 Impact on the Regional Markets
7. Market Analysis by Product
7.1.Duodenal stents
7.1.1.Duodenal stents Market Forecast, 2021-2029 (USD Million)
7.2.Biliary stents
7.2.1.Biliary stents Market Forecast, 2021-2029 (USD Million)
7.3. Pancreatic stents
7.3.1.Pancreatic stents Market Forecast, 2021-2029 (USD Million)
7.4.Oesophageal stents
7.4.1.Oesophageal stents Market Forecast, 2021-2029 (USD Million)
7.5.Colonic stents
7.5.1.Colonic stents Market Forecast, 2021-2029 (USD Million)
8. Market Analysis by Material
8.1.Nitinol
8.1.1.Nitinol Market Forecast, 2021-2029 (USD Million)
8.2.Self-expanding metal stents
8.2.1.Self-expanding metal stents Market Forecast, 2021-2029 (USD Million)
8.3.Stainless Steel
8.3.1.Stainless Steel Market Forecast, 2021-2029 (USD Million)
8.4.Plastic stents
8.4.1.Plastic stents Market Forecast, 2021-2029 (USD Million)
9. Market Analysis by Application
9.1.Colorectal Cancer
9.1.1.Colorectal Cancer Market Forecast, 2021-2029 (USD Million)
9.2.Stomach Cancer
9.2.1.Stomach Cancer Market Forecast, 2021-2029 (USD Million)
9.3.Pancreatic Cancer
9.3.1.Pancreatic Cancer Market Forecast, 2021-2029 (USD Million)
9.4.Biliary Diseases
9.4.1.Biliary Diseases Market Forecast, 2021-2029 (USD Million)
9.5.Irritable bowel syndrome
9.5.1.Irritable bowel syndrome Market Forecast, 2021-2029 (USD Million)
9.6.Gastrointestinal Cancers
9.6.1.Gastrointestinal Cancers Market Forecast, 2021-2029 (USD Million)
10. Market Analysis by End user
10.1.Ambulatory Surgical Centres
10.1.1.Ambulatory Surgical Centres Market Forecast, 2021-2029 (USD Million)
10.2.Hospitals & Clinics
10.2.1.Hospitals & Clinics Market Forecast, 2021-2029 (USD Million)
11. Regional Market Analysis
11.1.Regional Market Trends
11.2.Regional Market: Comparative Analysis
12. North America Gastrointestinal Stent Market
12.1.North America Gastrointestinal Stent Market
12.1.1.North America Market Size and Forecast, 2021-2029 (USD Million)
12.1.1.1.Market Size and Forecast by Product, 2021-2029 (USD Million)
12.1.1.2.Market Size and Forecast by Material, 2021-2029 (USD Million)
12.1.1.3.Market Size and Forecast by Application, 2021-2029 (USD Million)
12.1.1.4.Market Size and Forecast by End user, 2021-2029 (USD Million)
12.2.U.S. Gastrointestinal Stent Market
12.2.1.U.S. Market Size and Forecast, 2021-2029 (USD Million)
12.2.1.1.Market Size and Forecast by Product, 2021-2029 (USD Million)
12.2.1.2.Market Size and Forecast by Material, 2021-2029 (USD Million)
12.2.1.3.Market Size and Forecast by Application, 2021-2029 (USD Million)
12.2.1.4.Market Size and Forecast by End user, 2021-2029 (USD Million)
12.3.Canada Gastrointestinal Stent Market
12.3.1.Canada Market Size and Forecast, 2021-2029 (USD Million)
12.3.1.1.Market Size and Forecast by Product, 2021-2029 (USD Million)
12.3.1.2.Market Size and Forecast by Material, 2021-2029 (USD Million)
12.3.1.3.Market Size and Forecast by Application, 2021-2029 (USD Million)
12.3.1.4.Market Size and Forecast by End user, 2021-2029 (USD Million)
13. Europe Gastrointestinal Stent Market
13.1.Europe Gastrointestinal Stent Market
13.1.1.Europe Market Size and Forecast, 2021-2029 (USD Million)
13.1.1.1.Market Size and Forecast by Product, 2021-2029 (USD Million)
13.1.1.2.Market Size and Forecast by Material, 2021-2029 (USD Million)
13.1.1.3.Market Size and Forecast by Application, 2021-2029 (USD Million)
13.1.1.4.Market Size and Forecast by End user, 2021-2029 (USD Million)
13.2.Germany Gastrointestinal Stent Market
13.2.1.Germany Market Size and Forecast, 2021-2029 (USD Million)
13.2.1.1.Market Size and Forecast by Product, 2021-2029 (USD Million)
13.2.1.2.Market Size and Forecast by Material, 2021-2029 (USD Million)
13.2.1.3.Market Size and Forecast by Application, 2021-2029 (USD Million)
13.2.1.4.Market Size and Forecast by End user, 2021-2029 (USD Million)
13.3.UK Gastrointestinal Stent Market
13.3.1.UK Market Size and Forecast, 2021-2029 (USD Million)
13.3.1.1.Market Size and Forecast by Product, 2021-2029 (USD Million)
13.3.1.2.Market Size and Forecast by Material, 2021-2029 (USD Million)
13.3.1.3.Market Size and Forecast by Application, 2021-2029 (USD Million)
13.3.1.4.Market Size and Forecast by End user, 2021-2029 (USD Million)
13.4.France Gastrointestinal Stent Market
13.4.1.France Market Size and Forecast, 2021-2029 (USD Million)
13.4.1.1.Market Size and Forecast by Product, 2021-2029 (USD Million)
13.4.1.2.Market Size and Forecast by Material, 2021-2029 (USD Million)
13.4.1.3.Market Size and Forecast by Application, 2021-2029 (USD Million)
13.4.1.4.Market Size and Forecast by End user, 2021-2029 (USD Million)
13.5.Spain Gastrointestinal Stent Market
13.5.1.Spain Market Size and Forecast, 2021-2029 (USD Million)
13.5.1.1.Market Size and Forecast by Product, 2021-2029 (USD Million)
13.5.1.2.Market Size and Forecast by Material, 2021-2029 (USD Million)
13.5.1.3.Market Size and Forecast by Application, 2021-2029 (USD Million)
13.5.1.4.Market Size and Forecast by End user, 2021-2029 (USD Million)
13.6.Italy Gastrointestinal Stent Market
13.6.1.Italy Market Size and Forecast, 2021-2029 (USD Million)
13.6.1.1.Market Size and Forecast by Product, 2021-2029 (USD Million)
13.6.1.2.Market Size and Forecast by Material, 2021-2029 (USD Million)
13.6.1.3.Market Size and Forecast by Application, 2021-2029 (USD Million)
13.6.1.4.Market Size and Forecast by End user, 2021-2029 (USD Million)
13.7.Rest of EuropeGastrointestinal Stent Market
13.7.1.Rest of Europe Market Size and Forecast, 2021-2029 (USD Million)
13.7.1.1.Market Size and Forecast by Product, 2021-2029 (USD Million)
13.7.1.2.Market Size and Forecast by Material, 2021-2029 (USD Million)
13.7.1.3.Market Size and Forecast by Application, 2021-2029 (USD Million)
13.7.1.4.Market Size and Forecast by End user, 2021-2029 (USD Million)
14. Asia PacificGastrointestinal Stent Market
14.1.Asia PacificGastrointestinal Stent Market
14.1.1.Asia Pacific Market Size and Forecast, 2021-2029 (USD Million)
14.1.1.1.Market Size and Forecast by Product, 2021-2029 (USD Million)
14.1.1.2.Market Size and Forecast by Material, 2021-2029 (USD Million)
14.1.1.3.Market Size and Forecast by Application, 2021-2029 (USD Million)
14.1.1.4.Market Size and Forecast by End user, 2021-2029 (USD Million)
14.2.Japan Gastrointestinal Stent Market
14.2.1.Japan Market Size and Forecast, 2021-2029 (USD Million)
14.2.1.1.Market Size and Forecast by Product, 2021-2029 (USD Million)
14.2.1.2.Market Size and Forecast by Material, 2021-2029 (USD Million)
14.2.1.3.Market Size and Forecast by Application, 2021-2029 (USD Million)
14.2.1.4.Market Size and Forecast by End user, 2021-2029 (USD Million)
14.3.China Gastrointestinal Stent Market
14.3.1.China Market Size and Forecast, 2021-2029 (USD Million)
14.3.1.1.Market Size and Forecast by Product, 2021-2029 (USD Million)
14.3.1.2.Market Size and Forecast by Material, 2021-2029 (USD Million)
14.3.1.3.Market Size and Forecast by Application, 2021-2029 (USD Million)
14.3.1.4.Market Size and Forecast by End user, 2021-2029 (USD Million)
14.4.India Gastrointestinal Stent Market
14.4.1.India Market Size and Forecast, 2021-2029 (USD Million)
14.4.1.1.Market Size and Forecast by Product, 2021-2029 (USD Million)
14.4.1.2.Market Size and Forecast by Material, 2021-2029 (USD Million)
14.4.1.3.Market Size and Forecast by Application, 2021-2029 (USD Million)
14.4.1.4.Market Size and Forecast by End user, 2021-2029 (USD Million)
14.5.South Korea Gastrointestinal Stent Market
14.5.1.South Korea Market Size and Forecast, 2021-2029 (USD Million)
14.5.1.1.Market Size and Forecast by Product, 2021-2029 (USD Million)
14.5.1.2.Market Size and Forecast by Material, 2021-2029 (USD Million)
14.5.1.3.Market Size and Forecast by Application, 2021-2029 (USD Million)
14.5.1.4.Market Size and Forecast by End user, 2021-2029 (USD Million)
14.6.Australia Gastrointestinal Stent Market
14.6.1.Australia Market Size and Forecast, 2021-2029 (USD Million)
14.6.1.1.Market Size and Forecast by Product, 2021-2029 (USD Million)
14.6.1.2.Market Size and Forecast by Material, 2021-2029 (USD Million)
14.6.1.3.Market Size and Forecast by Application 2021-2029 (USD Million)
14.6.1.4.Market Size and Forecast by End user, 2021-2029 (USD Million)
14.7.Rest of Asia Pacific Gastrointestinal Stent Market
14.7.1.Rest of Asia Pacific Market Size and Forecast, 2021-2029 (USD Million)
14.7.1.1.Market Size and Forecast by Product, 2021-2029 (USD Million)
14.7.1.2.Market Size and Forecast by Material, 2021-2029 (USD Million)
14.7.1.3.Market Size and Forecast by Application, 2021-2029 (USD Million)
14.7.1.4.Market Size and Forecast by End user, 2021-2029 (USD Million)
15. Latin America Gastrointestinal Stent Market
15.1.Latin America Gastrointestinal Stent Market
15.1.1.Latin America Market Size and Forecast, 2021-2029 (USD Million)
15.1.1.1.Market Size and Forecast by Product, 2021-2029 (USD Million)
15.1.1.2.Market Size and Forecast by Material, 2021-2029 (USD Million)
15.1.1.3.Market Size and Forecast by Application, 2021-2029 (USD Million)
15.1.1.4.Market Size and Forecast by End user, 2021-2029 (USD Million)
15.2.BrazilGastrointestinal Stent Market
15.2.1.Brazil Market Size and Forecast, 2021-2029 (USD Million)
15.2.1.1.Market Size and Forecast by Application, 2021-2029 (USD Million)
15.2.1.2.Market Size and Forecast by Material, 2021-2029 (USD Million)
15.2.1.3.Market Size and Forecast by Application, 2021-2029 (USD Million)
15.2.1.4.Market Size and Forecast by End user, 2021-2029 (USD Million)
15.3.MexicoGastrointestinal Stent Market
15.3.1.Mexico Market Size and Forecast, 2021-2029 (USD Million)
15.3.1.1.Market Size and Forecast by Product, 2021-2029 (USD Million)
15.3.1.2.Market Size and Forecast by Material, 2021-2029 (USD Million)
15.3.1.3.Market Size and Forecast by Application, 2021-2029 (USD Million)
15.3.1.4.Market Size and Forecast by End user, 2021-2029 (USD Million)
15.4.Argentina Gastrointestinal Stent Market
15.4.1.Argentina Market Size and Forecast, 2021-2029 (USD Million)
15.4.1.1.Market Size and Forecast by Product, 2021-2029 (USD Million)
15.4.1.2.Market Size and Forecast by Material, 2021-2029 (USD Million)
15.4.1.3.Market Size and Forecast by Application, 2021-2029 (USD Million)
15.4.1.4.Market Size and Forecast by End user, 2021-2029 (USD Million)
15.5.Rest of Latin America Gastrointestinal Stent Market
15.5.1.Rest of Latin America Market Size and Forecast, 2021-2029 (USD Million)
15.5.1.1.Market Size and Forecast by Product, 2021-2029 (USD Million)
15.5.1.2.Market Size and Forecast by Material, 2021-2029 (USD Million)
15.5.1.3.Market Size and Forecast by Application, 2021-2029 (USD Million)
15.5.1.4.Market Size and Forecast by End user, 2021-2029 (USD Million)
16. MEAGastrointestinal Stent Market
16.1.MEA Gastrointestinal Stent Market
16.1.1.MEA Market Size and Forecast, 2021-2029 (USD Million)
16.1.1.1.Market Size and Forecast by Product, 2021-2029 (USD Million)
16.1.1.2.Market Size and Forecast by Material, 2021-2029 (USD Million)
16.1.1.3.Market Size and Forecast by Application, 2021-2029 (USD Million)
16.1.1.4.Market Size and Forecast by End user, 2021-2029 (USD Million)
16.2.GCC Gastrointestinal Stent Market
16.2.1.GCC Market Size and Forecast, 2021-2029 (USD Million)
16.2.1.1.Market Size and Forecast by Product, 2021-2029 (USD Million)
16.2.1.2.Market Size and Forecast by Material, 2021-2029 (USD Million)
16.2.1.3.Market Size and Forecast by Application, 2021-2029 (USD Million)
16.2.1.4.Market Size and Forecast by End user, 2021-2029 (USD Million)
16.3.South Africa Gastrointestinal Stent Market
16.3.1.South Africa Market Size and Forecast, 2021-2029 (USD Million)
16.3.1.1.Market Size and Forecast by Product, 2021-2029 (USD Million)
16.3.1.2.Market Size and Forecast by Material, 2021-2029 (USD Million)
16.3.1.3.Market Size and Forecast by Application, 2021-2029 (USD Million)
16.3.1.4.Market Size and Forecast by End user, 2021-2029 (USD Million)
16.4.Rest of MEA Gastrointestinal Stent Market
16.4.1.Rest of MEA Market Size and Forecast, 2021-2029 (USD Million)
16.4.1.1.Market Size and Forecast by Product, 2021-2029 (USD Million)
16.4.1.2.Market Size and Forecast by Material, 2021-2029 (USD Million)
16.4.1.3.Market Size and Forecast by Application, 2021-2029 (USD Million)
16.4.1.4.Market Size and Forecast by End user, 2021-2029 (USD Million)
17. Competitor Analysis
17.1.Market Share Analysis, 2021 & 2029
17.2.Competitive Mapping
17.3.Key Players Market Place Analysis
17.4.Major Recent Developments
18. Company Profiles
18.1.Boston Scientific Corporation (US)
18.1.1.Company Snapshot
18.1.2.Company Overview
18.1.3.Financials
18.1.4.Material Benchmarking
18.1.5.Recent Developments
18.2.Cook Group (US)
18.2.1.Company Snapshot
18.2.2.Company Overview
18.2.3.Financials
18.2.4.Material Benchmarking
18.2.5.Recent Developments
18.3.Medtronic plc. (Ireland)
18.3.1.Company Snapshot
18.3.2.Company Overview
18.3.3.Financials
18.3.4.Material Benchmarking
18.3.5.Recent Developments
18.4.ELLA-CS, s.r.o. (Czech Republic)
18.4.1.Company Snapshot
18.4.2.Company Overview
18.4.3.Financials
18.4.4.Material Benchmarking
18.4.5.Recent Developments
18.5.Becton, Dickinson, and Company (US)
18.5.1.Company Snapshot
18.5.2.Company Overview
18.5.3.Financials
18.5.4.Material Benchmarking
18.5.5.Recent Developments
18.6.CONMED Corporation (US)
18.6.1.Company Snapshot
18.6.2.Company Overview
18.6.3.Financials
18.6.4.Material Benchmarking
18.6.5.Recent Developments
18.7. Cantel Medical (US)
18.7.1.Company Snapshot
18.7.2.Company Overview
18.7.3.Financials
18.7.4.Material Benchmarking
18.7.5.Recent Developments
18.8.Olympus Corporation (Japan)
18.8.1.Company Snapshot
18.8.2.Company Overview
18.8.3.Financials
18.8.4.Material Benchmarking
18.8.5.Recent Developments
18.9.Taewoong Medical (South Korea)
18.9.1.Company Snapshot
18.9.2.Company Overview
18.9.3.Financials
18.9.4.Material Benchmarking
18.9.5.Recent Developments
18.10.Micro-Tech (Nanjing) Co., Ltd. (China),
18.10.1.Company Snapshot
18.10.2.Company Overview
18.10.3.Financials
18.10.4.Material Benchmarking
18.10.5.Recent Developments
18.11.Endo-Flex GmbH (Germany)
18.11.1.Company Snapshot
18.11.2.Company Overview
18.11.3.Financials
18.11.4.Material Benchmarking
18.11.5.Recent Developments
18.12.MI-Tech (South Korea)
18.12.1.Company Snapshot
18.12.2.Company Overview
18.12.3.Financials
18.12.4.Material Benchmarking
18.12.5.Recent Developments
18.13.Hobbs Medical Inc. (US)
18.13.1.Company Snapshot
18.13.2.Company Overview
18.13.3.Financials
18.13.4.Material Benchmarking
18.13.5.Recent Developments
18.14.QualiMed (Germany)
18.14.1.Company Snapshot
18.14.2.Company Overview
18.14.3.Financials
18.14.4.Material Benchmarking
18.14.5.Recent Developments
18.15. UK Medical (UK)
18.15.1.Company Snapshot
18.15.2.Company Overview
18.15.3.Financials
18.15.4.Material Benchmarking
18.15.5.Recent Developments
18.16.Others Prominent Players
19. Conclusion & Recommendations

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Boston Scientific Corporation (US)
  • Cook Group (US)
  • Medtronic plc. (Ireland)
  • ELLA-CS
  • s.r.o. (Czech Republic)
  • Becton
  • Dickinson and Company (US)
  • Merit Medical Systems (US)
  • CONMED Corporation (US)
  • Cantel Medical (US)
  • Olympus Corporation (Japan)
  • Taewoong Medical (South Korea)
  • Micro-Tech(Nanjing) Co. Ltd. (China)
  • Endo-Flex GmbH (Germany)
  • MI-Tech (South Korea)
  • Hobbs Medical Inc. (US)
  • QualiMed (Germany)
  • UK Medical (UK)
  • CITEC (China)
  • Medorah Meditek Pvt. Ltd. (India)
  • BCM Corporation (South Korea)
  • Leufen Medical GmbH (Germany).